98 related articles for article (PubMed ID: 21423934)
1. Synthesis and in vitro insulin-mimetic activities of zinc(ii) complexes of ethyl 2,5-dihydro-4-hydroxy-5-oxo-1H-pyrrole-3-carboxylates.
Kawarada H; Yoshikawa Y; Yasui H; Kuwahara S; Habata Y; Saito R
Metallomics; 2011 Jul; 3(7):675-9. PubMed ID: 21423934
[TBL] [Abstract][Full Text] [Related]
2. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities.
Yamaguchi M; Wakasugi K; Saito R; Adachi Y; Yoshikawa Y; Sakurai H; Katoh A
J Inorg Biochem; 2006 Feb; 100(2):260-9. PubMed ID: 16387366
[TBL] [Abstract][Full Text] [Related]
3. The action mechanism of zinc(II) complexes with insulinomimetic activity in rat adipocytes.
Yoshikawa Y; Ueda E; Kojima Y; Sakurai H
Life Sci; 2004 Jun; 75(6):741-51. PubMed ID: 15172182
[TBL] [Abstract][Full Text] [Related]
4. A new insulin-mimetic bis(allixinato)zinc(II) complex: structure-activity relationship of zinc(II) complexes.
Adachi Y; Yoshida J; Kodera Y; Kato A; Yoshikawa Y; Kojima Y; Sakurai H
J Biol Inorg Chem; 2004 Oct; 9(7):885-93. PubMed ID: 15378407
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of insulin-mimetic activities of vanadyl and zinc(II) complexes from the viewpoint of heterocyclic bidentate ligands.
Katoh A; Matsumura Y; Yoshikawa Y; Yasui H; Sakurai H
J Inorg Biochem; 2009 Apr; 103(4):567-74. PubMed ID: 19162327
[TBL] [Abstract][Full Text] [Related]
6. A novel and one-pot synthesis of new 1-tosyl pyrrol-2-one derivatives and analysis of carbonic anhydrase inhibitory potencies.
Alp C; Ekinci D; Gültekin MS; Sentürk M; Sahin E; Küfrevioğlu OI
Bioorg Med Chem; 2010 Jun; 18(12):4468-74. PubMed ID: 20554206
[TBL] [Abstract][Full Text] [Related]
7. The pharmacology of the insulinomimetic effect of zinc complexes.
Sakurai H; Adachi Y
Biometals; 2005 Aug; 18(4):319-23. PubMed ID: 16158223
[TBL] [Abstract][Full Text] [Related]
8. Research on antibacterial and antifungal agents. XIII. Synthesis and antimicrobial activity of 1-arylmethyl-4-aryl-1H-pyrrole-3-carboxylic acids.
Massa S; Di Santo R; Mai A; Botta M; Artico M; Panico S; Simonetti G
Farmaco; 1990 Jul; 45(7-8):833-46. PubMed ID: 2282118
[TBL] [Abstract][Full Text] [Related]
9. A family of insulinomimetic zinc(II) complexes of amino ligands with Zn(Nn) (n=3 and 4) coordination modes.
Yoshikawa Y; Kondo M; Sakurai H; Kojima Y
J Inorg Biochem; 2005 Jul; 99(7):1497-503. PubMed ID: 15921760
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the insulin-like properties of zinc(II) complexes of 3-hydroxy-4-pyridinones: identification of a compound with glucose lowering effect in STZ-induced type I diabetic animals.
Moniz T; Amorim MJ; Ferreira R; Nunes A; Silva A; Queirós C; Leite A; Gameiro P; Sarmento B; Remião F; Yoshikawa Y; Sakurai H; Rangel M
J Inorg Biochem; 2011 Dec; 105(12):1675-82. PubMed ID: 22088976
[TBL] [Abstract][Full Text] [Related]
11. Effects of Zn(II) complex with vitamins C and U, and carnitine on metabolic syndrome model rats.
Matsumoto K; Motoyasu N; Sera K; Fujii T; Yoshikawa Y; Yasui H; Taniguchi H; Kajiwara N
Metallomics; 2011 Jul; 3(7):683-5. PubMed ID: 21701765
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, crystal structures, and anti-convulsant activities of ternary [Zn(II)(3,5-diisopropylsalicylate)(2)], [Zn(II)(salicylate)(2)] and [Zn(II)(aspirinate)(2)] complexes.
Lemoine P; Viossat B; Dung NH; Tomas A; Morgant G; Greenaway FT; Sorenson JR
J Inorg Biochem; 2004 Nov; 98(11):1734-49. PubMed ID: 15522401
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization and DNA-binding properties of four Zn(II) complexes with bis(pyrrol-2-yl-methyleneamine) ligands.
Wang Y; Yang ZY; Chen ZN
Bioorg Med Chem Lett; 2008 Jan; 18(1):298-303. PubMed ID: 18023579
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, structure, and photophysical characterization of blue-green luminescent zinc complexes containing 2-iminophenanthropyrrolyl ligands.
Gomes CS; Gomes PT; Duarte MT; Di Paolo RE; Maçanita AL; Calhorda MJ
Inorg Chem; 2009 Dec; 48(23):11176-86. PubMed ID: 19863089
[TBL] [Abstract][Full Text] [Related]
15. Development of new insulinomimetic zinc(II) picolinate complexes with a Zn(N2O2) coordination mode: structure characterization, in vitro, and in vivo studies.
Yoshikawa Y; Ueda E; Kawabe K; Miyake H; Takino T; Sakurai H; Kojima Y
J Biol Inorg Chem; 2002 Jan; 7(1-2):68-73. PubMed ID: 11862542
[TBL] [Abstract][Full Text] [Related]
16. A [meso-tetrakis(4-sulfonatophenyl)porphyrinato]zinc(ii) complex as an oral therapeutic for the treatment of type 2 diabetic KKA(y) mice.
Saha TK; Yoshikawa Y; Sakurai H
ChemMedChem; 2007 Feb; 2(2):218-25. PubMed ID: 17245806
[TBL] [Abstract][Full Text] [Related]
17. 3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 2. Effect of pyrrole-C2 and/or -C4 substitutions on biological activity.
Mai A; Massa S; Cerbara I; Valente S; Ragno R; Bottoni P; Scatena R; Loidl P; Brosch G
J Med Chem; 2004 Feb; 47(5):1098-109. PubMed ID: 14971890
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and insulin-mimetic activities of metal complexes with 3-hydroxypyridine-2-carboxylic acid.
Nakai M; Sekiguchi F; Obata M; Ohtsuki C; Adachi Y; Sakurai H; Orvig C; Rehder D; Yano S
J Inorg Biochem; 2005 Jun; 99(6):1275-82. PubMed ID: 15917081
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, structures and reactivity of 2-phosphorylmethyl-1H-pyrrolato complexes of titanium, yttrium and zinc.
Broomfield LM; Wright JA; Bochmann M
Dalton Trans; 2009 Oct; (39):8269-79. PubMed ID: 19789779
[TBL] [Abstract][Full Text] [Related]
20. Examination of novel zinc-binding groups for use in matrix metalloproteinase inhibitors.
Puerta DT; Cohen SM
Inorg Chem; 2003 Jun; 42(11):3423-30. PubMed ID: 12767177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
